Plasma LDL cholesterol is a well-established predictor of coronary artery disease (CAD), and many observations have pointed out that Lp(a) and apolipoprotein(a) (apo(a)) levels may be risk factors for cardiovascular diseases (CVD) [6–8]. This evidence concerns the gene LPA and coronary artery disorder.